Castle Biosciences (CSTL) Asset Utilization Ratio (2019 - 2026)

Castle Biosciences has reported Asset Utilization Ratio for 8 years, with the latest figure at 0.64 in Q2 2026.

• Quarterly Asset Utilization Ratio fell 2.64% year-over-year to 0.64 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.64 (down 2.64% YoY) and the FY2025 annual result came in at 0.62, down 8.03% from the prior year.
• Asset Utilization Ratio grew to 0.64 in Q2 2026 per CSTL's latest filing, from 0.6 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.67 in Q1 2025 and troughed at 0.22 in Q1 2022.
• A 5-year average of 0.5 and a median of 0.58 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio surged 65.04% in 2023, then fell 10.19% in 2026.
• Over 5 years, Asset Utilization Ratio stood at 0.3 in 2022, then jumped by 63.23% to 0.49 in 2023, then gained by 28.49% to 0.64 in 2024, then retreated by 5.02% to 0.6 in 2025, then rose by 6.82% to 0.64 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.64, 0.6, and 0.6 for Q2 2026, Q1 2026, and Q4 2025 respectively.